(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ASCENTX MEDICAL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ASCENTX MEDICAL

ST13

US500000088579316

Class

42

Filing

88579316

Registration

6641806

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

02/15/2022

Trademark type

Word

Nice classes

42

Filing date

08/14/2019

Registration date

02/15/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/15/2022

Last transaction

02/15/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

08/01/2008

First use in commerce

08/01/2008

Drawing code

4

Owner type

03

Owner location

San Diego, CA

Examiner

BAYLISS,HUNTER A

Law office

M40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Ascentx Medical, Inc.

Representatives

Karen Hawkes, Esq. HAWKES LAW, APLC

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Design and development of medical technologythe clinical development of unique permanent bulking agent platform technology to treat medical conditions

Publications

History of USPTO decisions and trademark events.

23 publications found

R.PR

REGISTERED-PRINCIPAL REGISTER

02/15/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/30/2021

PUBO

PUBLISHED FOR OPPOSITION

11/30/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/10/2021

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

10/22/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/22/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/14/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/14/2021

ALIE

ASSIGNED TO LIE

10/14/2021

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

10/08/2021

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

07/06/2021

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

12/16/2020

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

06/18/2020

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

12/09/2019

GNSL

LETTER OF SUSPENSION E-MAILED

12/09/2019

CNSL

SUSPENSION LETTER WRITTEN

12/09/2019

XAEC

EXAMINER'S AMENDMENT ENTERED

11/20/2019

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/20/2019

GNEA

EXAMINERS AMENDMENT E-MAILED

11/20/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/20/2019

DOCK

ASSIGNED TO EXAMINER

11/13/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/29/2019

NWAP

NEW APPLICATION ENTERED

08/17/2019

Continuous trademark protection

Get notified about every new filing that threatens ASCENTX MEDICAL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.